Keyphrases
Nuclear factor-κB
100%
Induced Apoptosis
100%
Spironolactone
100%
Mineralocorticoid Receptor
100%
Sulfasalazine
36%
Apoptosis
27%
Inflammatory Cytokines
18%
Mononuclear Cells
18%
Apoptotic Effect
18%
Receptor Binding
9%
Anti-inflammatory Drugs
9%
Transcription Factor
9%
Phosphorylation
9%
IκBα
9%
Cell Death
9%
Aldosterone Antagonists
9%
Immuno-inflammatory Response
9%
Aldosterone
9%
Suppression Effect
9%
Anti-inflammatory Effect
9%
Mineralocorticoid Receptor Antagonists
9%
Apoptosis-inducing Activity
9%
Cytokine Suppression
9%
Eplerenone
9%
Receptor-independent
9%
Immunology and Microbiology
Sulfasalazine
100%
Mononuclear Cell
50%
Inflammatory Cytokine
50%
Cytokine
25%
Receptor Binding
25%
Transcription Factors
25%
Metabolite
25%
Antiinflammatory Activity
25%
Cell Death
25%
Chemistry
Mineralocorticoid
100%
Spironolactone
100%
Sulfasalazine
36%
Apoptotic
27%
Antiinflammatory
18%
Metabolite
9%
Phosphorylation
9%
Aldosterone Antagonist
9%
Cell Death
9%
Mineralocorticoid Antagonist
9%
Eplerenone
9%
Aldosterone
9%
Biochemistry, Genetics and Molecular Biology
Mineralocorticoid Receptor
100%
Spironolactone
100%
Sulfasalazine
36%
Aldosterone
18%
Inflammatory Cytokine
18%
Cell Death
9%
Metabolite
9%
Cytokine
9%
Transcription Factors
9%
Receptor Binding
9%
Antiinflammatory Activity
9%
Receptor Antagonist
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mineralocorticoid Receptor
100%
Spironolactone
100%
Sulfasalazine
36%
Cytokine
27%
Antiinflammatory Agent
9%
Transcription Factors
9%
Antiinflammatory Activity
9%
Aldosterone Antagonist
9%
Mineralocorticoid Antagonist
9%
Eplerenone
9%
Aldosterone
9%
Neuroscience
Mineralocorticoid Receptor
100%
Spironolactone
100%
Sulfasalazine
36%
Receptor Binding
9%
Anti-Inflammatory
9%
Receptor Antagonist
9%
Cell Death
9%
Transcription Factors
9%
Aldosterone
9%
Eplerenone
9%
Aldosterone Antagonist
9%